These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18556064)
21. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily. Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722 [TBL] [Abstract][Full Text] [Related]
22. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. Bosello S; Youinou P; Daridon C; Tolusso B; Bendaoud B; Pietrapertosa D; Morelli A; Ferraccioli G J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969 [TBL] [Abstract][Full Text] [Related]
23. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia. Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763 [TBL] [Abstract][Full Text] [Related]
24. Serum BAFF and APRIL levels in patients with PBC. Migita K; Ilyassova B; Kovzel EF; Nersesov A; Abiru S; Maeda Y; Komori A; Ito M; Yano K; Yatsuhashi H; Shimoda S; Ishibashi H; Nakamura M Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
26. Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. Gora-Tybor J; Blonski JZ; Robak T Neoplasma; 2002; 49(3):145-8. PubMed ID: 12097998 [TBL] [Abstract][Full Text] [Related]
27. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia. Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442 [TBL] [Abstract][Full Text] [Related]
28. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris. Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171 [TBL] [Abstract][Full Text] [Related]
30. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816 [TBL] [Abstract][Full Text] [Related]
31. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889 [TBL] [Abstract][Full Text] [Related]
32. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia. Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374 [TBL] [Abstract][Full Text] [Related]
34. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression. Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522 [TBL] [Abstract][Full Text] [Related]
35. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia. Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016 [TBL] [Abstract][Full Text] [Related]
36. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis. Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352 [TBL] [Abstract][Full Text] [Related]
37. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF. Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803 [TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders. Duek A; Shvidel L; Braester A; Berrebi A Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095 [TBL] [Abstract][Full Text] [Related]
39. Serum CA 125 levels in patients with chronic lymphocytic leukemia. Bairey O; Shaklai M Clin Lab Haematol; 2005 Feb; 27(1):57-60. PubMed ID: 15686509 [TBL] [Abstract][Full Text] [Related]
40. Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis. Martinelli S; Maffei R; Castelli I; Santachiara R; Zucchini P; Fontana M; Bonacorsi G; Leonardi G; Marasca R; Torelli G Leuk Res; 2008 Apr; 32(4):593-7. PubMed ID: 17928052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]